Key points are not available for this paper at this time.
AZA is a modestly effective treatment for NMO. However, many patients discontinue AZA over time and this seems to reflect poor tolerability more than lack of efficacy.
Building similarity graph...
Analyzing shared references across papers
Loading...
Liene Elsone
Joanna Kitley
Sebastian Luppe
Multiple Sclerosis Journal
University of Liverpool
John Radcliffe Hospital
University Hospital of Wales
Building similarity graph...
Analyzing shared references across papers
Loading...
Elsone et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d978e88988aeabbe685697 — DOI: https://doi.org/10.1177/1352458514525870